Brain Distributional Kinetics of a Novel MDM2 Inhibitor SAR405838: Implications for Use in Brain Tumor Therapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Brain Distributional Kinetics of a Novel MDM2 Inhibitor SAR405838: Implications for Use in Brain Tumor Therapy
Authors
Keywords
-
Journal
DRUG METABOLISM AND DISPOSITION
Volume 47, Issue 12, Pages 1403-1414
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Online
2019-10-17
DOI
10.1124/dmd.119.088716
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacokinetic Assessment of Cooperative Efflux of the Multitargeted Kinase Inhibitor Ponatinib Across the Blood-Brain Barrier
- (2018) Janice K. Laramy et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Efficacy of the MDM2 inhibitor SAR405838 in glioblastoma is limited by poor distribution across the blood-brain barrier
- (2018) Minjee Kim et al. MOLECULAR CANCER THERAPEUTICS
- Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine
- (2018) Minjee Kim et al. PHARMACEUTICAL RESEARCH
- Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data
- (2017) Jann N Sarkaria et al. NEURO-ONCOLOGY
- TP53 mutations emerge with HDM2 inhibitor SAR405838 treatment in de-differentiated liposarcoma
- (2016) Joonil Jung et al. Nature Communications
- Management of acquired resistance to epidermal growth factor receptor kinase inhibitors in patients with advanced non-small cell lung cancer
- (2014) Adrian G. Sacher et al. CANCER
- SAR405838: An Optimized Inhibitor of MDM2-p53 Interaction That Induces Complete and Durable Tumor Regression
- (2014) S. Wang et al. CANCER RESEARCH
- Development and Evaluation of a Novel Microemulsion Formulation of Elacridar to Improve its Bioavailability
- (2013) Ramola Sane et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study
- (2013) D. H. Pafundi et al. NEURO-ONCOLOGY
- Breast Cancer Resistance Protein and P-Glycoprotein in Brain Cancer: Two Gatekeepers Team Up
- (2012) Sagar Agarwal et al. CURRENT PHARMACEUTICAL DESIGN
- Structure–Activity Relationships, Ligand Efficiency, and Lipophilic Efficiency Profiles of Benzophenone-Type Inhibitors of the Multidrug Transporter P-Glycoprotein
- (2012) Ishrat Jabeen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain
- (2011) Sagar Agarwal et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
- (2011) Yasuo Uchida et al. JOURNAL OF NEUROCHEMISTRY
- Heterogeneous Blood-Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer
- (2010) P. R. Lockman et al. CLINICAL CANCER RESEARCH
- Kinetic Analysis of the Cooperation of P-Glycoprotein (P-gp/Abcb1) and Breast Cancer Resistance Protein (Bcrp/Abcg2) in Limiting the Brain and Testis Penetration of Erlotinib, Flavopiridol, and Mitoxantrone
- (2010) H. Kodaira et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Improved Measurement of Drug Exposure in the Brain Using Drug-Specific Correction for Residual Blood
- (2009) Markus Fridén et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Unbound Drug Concentration in Brain Homogenate and Cerebral Spinal Fluid at Steady State as a Surrogate for Unbound Concentration in Brain Interstitial Fluid
- (2008) X. Liu et al. DRUG METABOLISM AND DISPOSITION
- Validation of a Rapid Equilibrium Dialysis Approach for the Measurement of Plasma Protein Binding
- (2008) Nigel J. Waters et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started